First CRISPR gene-editing therapy accepted in U.S.
The U.S. Meals and Drug Administration on Friday accepted the nation’s first gene-editing therapy, Casgevy, to be used in sufferers with sickle cell illness. The approval comes a couple of…
The U.S. Meals and Drug Administration on Friday accepted the nation’s first gene-editing therapy, Casgevy, to be used in sufferers with sickle cell illness. The approval comes a couple of…